Login Register
English
0

Cart

$ 0

ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation(A23410-8.698)

Date:2021-04-07 Views:37